These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 3657853

  • 1. [Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B].
    Polak A.
    Mykosen; 1987 Jul; 30(7):306-8, 311-4. PubMed ID: 3657853
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract] [Full Text] [Related]

  • 6. Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.
    Lauer BA, Reller LB, Schröter GP.
    J Antimicrob Chemother; 1978 Jul; 4(4):375-80. PubMed ID: 690038
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 Jul; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
    Majoros L, Kardos G, Feiszt P, Szabó B.
    J Antimicrob Chemother; 2005 Jul; 56(1):253-4. PubMed ID: 15911550
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antifungal resistance in pathogenic fungi.
    Perea S, Patterson TF.
    Clin Infect Dis; 2002 Nov 01; 35(9):1073-80. PubMed ID: 12384841
    [Abstract] [Full Text] [Related]

  • 17. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA.
    Rev Inst Med Trop Sao Paulo; 1979 Nov 01; 21(6):344-6. PubMed ID: 550288
    [No Abstract] [Full Text] [Related]

  • 18. [Analysis of resistance of yeast-like fungi to 5-fluorocytosine].
    Pawlik B, Barylak J.
    Med Dosw Mikrobiol; 1979 Nov 01; 31(4):277-82. PubMed ID: 575664
    [No Abstract] [Full Text] [Related]

  • 19. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP.
    J Antimicrob Chemother; 2006 Feb 01; 57(2):236-44. PubMed ID: 16361329
    [Abstract] [Full Text] [Related]

  • 20. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM.
    Sabouraudia; 1972 Nov 01; 10(3):276-83. PubMed ID: 4565443
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.